State Street Corp Aslan Pharmaceuticals LTD Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.44 - $3.2 $18,693 - $135,955	-42,486 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$0.36 - $0.6 $1,585 - $2,641	4,403 Added 11.56%	42,486 $15,000
Q3 2022 Nov 15, 2022	BUY	$0.42 - $0.94 $869 - $1,945	2,070 Added 5.75%	38,083 $23,000
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.9 $99 - $248	-276 Reduced 0.76%	36,013 $18,000
Q1 2022 May 16, 2022	BUY	$0.74 - $1.22 $3,863 - $6,369	5,221 Added 16.81%	36,289 $32,000

Q4 2021 Feb 14, 2022	SELL	$1.11 - $1.86 $72,772 - $121,943	-65,561 Reduced 67.85%	31,068 $35,000
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $114,365 - $219,092	64,250 Added 198.43%	96,629 $172,000
Q1 2021 May 17, 2021	BUY	$1.86 - $5.25 $7,400 - $20,889	3,979 Added 14.01%	32,379 $108,000
Q4 2020 Feb 16, 2021	BUY	$1.54 - $2.22 $43,736 - $63,048	28,400 New	28,400 $52,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $20.9M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.